27Mar Dr. Lal PathLabs submits analyst meet Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
23Mar Dr. Lal PathLabs informs about instituPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
21Mar Dr. Lal PathLabs informs about resignaIn furtherance to letter dated February 14, 2023 Dr. Lal PathLabs has in..
17Mar Dr. Lal PathLabs informs about analystPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
15Mar Dr. Lal PathLabs informs about analystPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..